Montana has approved its first treatment under an expanded right-to-try law, allowing patients to access an experimental sound-and-antihistamine therapy aimed at restoring hearing loss. The move comes as part of broader efforts to provide access to unapproved medical treatments for serious conditions when conventional options have been exhausted. Critics and supporters alike are closely watching how the program balances patient access with potential risks, as similar initiatives have faced scrutiny over safety and efficacy. The decision marks a significant step in Montana’s approach to alternative therapies outside traditional regulatory pathways.
Montana’s expanded right-to-try program has cleared its first therapy: a sound-and-antihistamine regimen to reverse hearing loss.
